Cegedim SA (EPA:ALCGM)
10.30
-0.22 (-2.09%)
Oct 22, 2026, 5:35 PM CEST
Cegedim Revenue
Cegedim had revenue of 324.84M EUR in the half year ending June 30, 2026, with 1.83% growth. This brings the company's total for the last twelve months to 651.52M, down -0.98% year-over-year. In the year 2025, Cegedim had annual revenue of 649.17M, down -0.81%. That makes Cegedim the 9,129th largest company in the world by revenue and 168th in France.
Revenue (ttm)
651.52M
Revenue Growth
-0.98%
P/S Ratio
0.22
Revenue / Employee
100.43K
Employees
6,487
Market Cap
141.43M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Cegedim breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 649.17M | -5.32M | -0.81% |
| Dec 31, 2024 | 654.50M | 38.50M | 6.25% |
| Dec 31, 2023 | 616.00M | 60.79M | 10.95% |
| Dec 31, 2022 | 555.21M | 30.50M | 5.81% |
| Dec 31, 2021 | 524.71M | 27.77M | 5.59% |
| Dec 31, 2020 | 496.94M | -6.81M | -1.35% |
| Dec 31, 2019 | 503.75M | 36.06M | 7.71% |
| Dec 31, 2018 | 467.69M | 10.25M | 2.24% |
| Dec 31, 2017 | 457.44M | 28.19M | 6.57% |
| Dec 31, 2016 | 429.25M | 3.09M | 0.73% |
| Dec 31, 2015 | 426.16M | 13.91M | 3.37% |
| Dec 31, 2014 | 412.25M | -490.01M | -54.31% |
| Dec 31, 2013 | 902.26M | -19.52M | -2.12% |
| Dec 31, 2012 | 921.77M | 10.31M | 1.13% |
| Dec 31, 2011 | 911.46M | -15.21M | -1.64% |
| Dec 31, 2010 | 926.67M | 52.60M | 6.02% |
| Dec 31, 2009 | 874.07M | 25.50M | 3.00% |
| Dec 31, 2008 | 848.58M | 95.58M | 12.69% |
| Dec 31, 2007 | 752.99M | 211.79M | 39.13% |
| Dec 31, 2006 | 541.21M | 39.87M | 7.95% |
| Dec 31, 2005 | 501.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Eurofins Scientific SE | 7.39B |
| Sartorius Stedim Biotech | 3.01B |
| Bastide Le Confort Médical | 510.46M |
| Eurofins-Cerep | 41.10M |
| Median Technologies | 23.47M |
| Innate Pharma | 9.81M |
Cegedim News
- 13 hours ago - Cegedim Earnings Call Transcript: Q3 2026 - Transcripts
- 13 hours ago - Cegedim Earnings release: Q3 2026 - Filings
- 13 hours ago - Cegedim Slides: Q3 2026 - Filings
- 4 weeks ago - Cegedim Earnings Call Transcript: H1 2026 - Transcripts
- 4 weeks ago - Cegedim Earnings release: H1 2026 - Filings
- 4 weeks ago - Cegedim Slides: H1 2026 - Filings
- 4 weeks ago - Cegedim Quarterly report: H1 2026 - Filings
- 3 months ago - Cegedim Earnings Call Transcript: Q2 2026 - Transcripts